Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, Identification of SMYD2 interactions and Substrates by Immunoprecipitation Coupled to MS, University of Ottawa
1 Sep 2005 → 1 May 2009
Award Date: 1 May 2009
| Supervised by |
|
|---|
Master, Regulation of Erythroid-Specific 5-Aminolevulinate Synthase (ALAS2) by Hypoxia, Carleton University - Canada's Capital University
1 Sep 2003 → 2 May 2005
Award Date: 2 May 2005
| Supervised by |
|
|---|
Bachelor, Hydroxilation And Protein Stability Under Hypoxia, Carleton University - Canada's Capital University
1 Sep 1998 → 1 May 2003
Award Date: 1 May 2003
| Supervised by |
|
|---|
External positions
Dasman Diabetes Institute
Fingerprint
Dive into the research topics where Mohamed Abu-Farha is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 5 Active
-
Improving glucose control of poorly controlled insulin treated T2DM patients in Kuwait
Al-Mulla, F. (PI), Abdulghani, M. (PI), Alajmi, F. (CoI), Abu-Farha, M. (CoI), AlEssa, T. (CoI), Al-Otaibi, N. (CoI), Shehab, M. (CoI) & Ahmed, M. (CoI)
1/05/24 → 1/05/29
Project: Dasman Diabetes Institute Projects
-
The Impact of GLP-1/GIP Dual Agonists in Addition to Pioglitazone on Adipose Tissue Metabolism and Their Role in Modulating Insulin Sensitivity and Beta Cell Function in Type 2 Diabetes Mellitus
Abu-Farha, M. (PI), Abdul-Ghani, M. (CoI), Abubaker, J. (CoI), Al-Khairi, I. (CoI), AlSabbagh, A. (CoI), Cherian, P. (CoI), Malik, M. (CoI), Qaddoumi, M. (CoI) & Thangavel, A. (CoI)
1/04/24 → 1/04/29
Project: Dasman Diabetes Institute Projects
-
Phase 2: Can Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?
Al-Mulla, F. (PI), Abdul-Ghani, M. (PI), Abu-Farha, M. (CoI), Al-Ajmi, F. (CoI), AlEssa, T. (CoI), Khalifa, D. (CoI), Abubaker, J. (CoI) & Devarajan, S. (CoI)
1/03/24 → 1/06/26
Project: Dasman Diabetes Institute Projects
-
Functional and Pharmacogenomic Characterization of Hallmark Genetic Risk variants for Metabolic Traits in The Kuwaiti Population: Enrichening KADEM and The Kuwait Variome Database
Thangavel, A. (PI), Al-Mulla, F. (PI), Abu-Farha, M. (CoI), Abubaker, J. (CoI), Dashti, M. (CoI), Malik, M. (CoI), Mohammed, A. (CoI), Iqbal, R. (CoI), Sriraman, D. (CoI), Melhem, M. (CoI), Mohamed Channanath, A. (CoI), Elsa John, S. (CoI), Jacob, S. (CoI), Al-Madhoon, A. (CoI) & Haddad, D. (CoI)
1/02/24 → 1/02/29
Project: Dasman Diabetes Institute Projects
-
Kuwait Diabetes Epidemiological Study Diabetes high risk Follow up study (KADEM)
Abu-Farha, M. (PI), Al-Mulla, F. (PI), Bennakhi, A. (PI), Abubaker, J. (PI), Abdulghani, M. (CoI), Al Ozairi, E. (CoI), Mohammed, A. (CoI), Sladek, R. (CoI), Sriraman, D. (CoI), Alkandari, A. (CoI), Ahmad, R. (CoI), Eaaswarkhanth, M. (CoI), Al-Madhoon, A. (CoI), Sindhu, S. (CoI), Al-Sharrah, S. (CoI), Arefanian, H. (CoI), Alterki, A. (CoI), Attar, A. A. (CoI), Hasan, A. (CoI), Haidar, A. (CoI), Saad, F. (CoI), Qaddoumi, M. G. (CoI), Alanbaei, M. (CoI), Al-Rashed, F. (CoI), Coffee, N. T. (CoI), Al-Ali, W. (CoI), Daniel, M. (CoI), Mathur, A. (CoI), Akther, N. (CoI), Akhter, N. (CoI), Thomas, R. (CoI), Kochumon, S. (CoI), Laiaqat, A. (CoI), Chandy, B. S. (CoI), Osman, M. (CoI), Melhem, M. (CoI), Al-Sultan, M. (CoI), Jose, R. M. (CoI), Warsam, S. (CoI), Joseph, S. (CoI), Atizado, V. L. (CoI), Vijayan, V. (CoI), Jalali, M. (CoI), Bennakhi, A. (CoI), Kavalakatt, S. (CoI) & Khadir, A. (CoI)
1/02/21 → 1/03/30
Project: Dasman Diabetes Institute Projects
-
Al-Ajmi, F., Abu-Farha, M., Albatineh, A. N., Ali, Z., AL-Enezi, A., Alterki, M., Alhammad, R., AlHarbi, R., Shehab, M., Abdul-Ghani, M., Abubaker, J., & Al-Mulla, F. (2025). Association of wrist circumference with metabolic dysfunction associated fatty liver disease in the KADEM cohort. Frontiers in Endocrinology, 16, Article 1580209. https://doi.org/10.3389/fendo.2025.1580209Open Access
-
Alshawaf, E., Marafie, S. K., Abu-Farha, M., Albatineh, A. N., Alramah, T., Albuhairi, A., Al Qassar, Y., Zinoun, R., Shalabi, R., Behbehani, S., Mohammed, D., Alajmi, F., Abdalla, M. A., Al-Ozairi, E., Shehab, M., Abdul-Ghani, M., Al-Mulla, F., & Abubaker, J. (2025). Circulating Isthmin-1 Levels and Their Relationship with Diabetes and Metabolic Diseases in Kuwaiti Adults. Biomedicines, 13(1), Article 101. https://doi.org/10.3390/biomedicines13010101Open Access1 Scopus citations
-
Abu-Farha, M., Albatineh, A. N., Alawadh, B., Alsalem, L., Al-Khairi, I., Cherian, P., Al-Ajmi, F., Qaddoumi, M., Abdul-Ghani, M., Al-Mulla, F., & Abubaker, J. (2025). Circulating ORM2 as a Biomarker of Metabolic Dysfunction: Evidence from the KADEM Study in Kuwaiti Adults. International Journal of Molecular Sciences, 26(17), Article 8326. https://doi.org/10.3390/ijms26178326Open Access
-
Thanaraj, T. A., Abu-Farha, M., Albatineh, A. N., Channanath, A., Melhem, M., Chandy, B., Anoop, E., Abubaker, J., & Al-Mulla, F. (2025). effect of ethnicity on the relationship between telomere length and metabolic markers in kuwait. Journal of Clinical Endocrinology and Metabolism. https://doi.org/10.1210/clinem/dgaf164
-
Thanaraj, T. A., Abu-Farha, M., Albatineh, A. N., Channanath, A., Melhem, M., Chandy, B., Anoop, E., Abubaker, J., & Al-Mulla, F. (2025). Effect of Ethnicity on the Relationship Between Telomere Length and Metabolic Markers in Kuwait. Journal of Clinical Endocrinology and Metabolism, 110(11), e3656-e3664. https://doi.org/10.1210/clinem/dgaf164Open Access